Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices

As this is a post-market registry on market approved devices, there will be no formal
hypothesis testing. However, points of evaluation will include:

- Characterize the efficacy of the AMS market approved female pelvic health products
using standard of care outcome measures and validated quality of life questionnaires

- Characterize the type, severity, and rate of adverse events related to each AMS market
approved female pelvic health product

- Collect concomitant procedural data related to the pelvic floor area

Inclusion Criteria:

- Patients must meet all of the following criteria to be considered for inclusion in
the registry.

- Have a signed Informed Consent Form

- Have a signed HIPAA Authorization Form or equivalent Patient Privacy Form if
required outside of the US

- Is a female at least 18 years of age

- Is scheduled to receive at least one (1) AMS market approved female pelvic
health implantable product.

- Is able and willing to participate in the registry

Exclusion Criteria:

- Patients will be excluded from the registry if any one of the following criteria is
met.

- Patients are contraindicated to receive the target AMS market approved female
pelvic health product per the product's IFU